Morgan Stanley Alzheimer Optimism Extending to Eli Lilly (LLY) Until Next Catalyst
Tweet Send to a Friend
Morgan Stanley analyst David Risinger reiterated an Overweight rating and $207.00 price target on Eli Lilly (NYSE: LLY) noting that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
